Document Detail


Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
MedLine Citation:
PMID:  9695737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Short chain fatty acids derived from dietary fiber may protect against invasive colon cancer by modulating degradative matrix metalloproteinases (MMPs) and protective tissue inhibitor matrix metalloproteinases (TIMPs). Since invasion depends on the MMP/TIMP ratio, we hypothesized that short chain fatty acids inhibit colon cancer invasion by inhibiting MMPs and stimulating TIMPs. MATERIALS AND METHODS: SW1116 colon cancer cells were seeded onto Matrigel-coated Boyden chambers and treated with unsupplemented media or media containing 10 mM acetate, propionate, or butyrate. SW1116 invasion was quantitated by light microscopy and conditioned media were assayed by ELISA for MMP-1,2,3,9; TIMP-1,2; MMP/TIMP complex; and urokinase plasminogen activator (uPA). All data are expressed as mean percentage of control +/- SE (n > 6). RESULTS: Although all three short chain fatty acids inhibited invasion, butyrate was more potent than either acetate or propionate, inhibiting SW1116 invasion by 35 +/- 1% of control (n = 18, P < .0001) vs. 18 +/- 9% (n = 7, P < .05) for acetate and 10 +/- 6% (n = 7, P < .05) for propionate. MMP-2 was not modulated by any of the short chain fatty acids while MMP-1 was modulated only by butyrate and MMP-3 by propionate. Acetate did not modulate MMPs, TIMP-1, or uPA, but stimulated TIMP-2. In contrast, propionate and butyrate stimulated MMP-9 and TIMP-2 by 119-233% and both inhibited uPA by 8-16%. TIMP-1 was stimulated only by butyrate and actually inhibited by propionate. Only butyrate stimulated both TIMP-1 and TIMP-2. CONCLUSIONS: These data suggest that dietary fiber may protect against invasive colon cancer through stimulation of TIMP and inhibition of uPA activities, rather than through short chain fatty acids effects on the activities of the MMPs studied.
Authors:
N J Emenaker; M D Basson
Related Documents :
15112737 - Straight and branched-chain fatty acids in preorbital glands of sika deer, cervus nippon.
9933617 - Why superoxide imposes an aromatic amino acid auxotrophy on escherichia coli. the trans...
15629937 - The bkdr gene of streptomyces coelicolor is required for morphogenesis and antibiotic p...
2503497 - Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell...
20709847 - Transcriptomic analysis of escherichia coli o157:h7 and k-12 cultures exposed to inorga...
1712767 - Effects of a parenteral supplement of folic acid and its interaction with level of feed...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of surgical research     Volume:  76     ISSN:  0022-4804     ISO Abbreviation:  J. Surg. Res.     Publication Date:  1998 Apr 
Date Detail:
Created Date:  1998-08-20     Completed Date:  1998-08-20     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0376340     Medline TA:  J Surg Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  41-6     Citation Subset:  IM    
Affiliation:
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / pharmacology
Adenocarcinoma
Butyrates / pharmacology
Cell Division / drug effects
Colonic Neoplasms
Dietary Fiber / metabolism
Enzyme Activation / drug effects
Fatty Acids, Volatile / pharmacology*
Humans
Metalloendopeptidases / metabolism
Neoplasm Invasiveness / physiopathology*
Propionates / pharmacology
Protease Inhibitors / metabolism*
Tissue Inhibitor of Metalloproteinase-1 / metabolism*
Tissue Inhibitor of Metalloproteinase-2 / metabolism*
Tumor Cells, Cultured / cytology,  drug effects,  enzymology
Urokinase-Type Plasminogen Activator / metabolism*
Chemical
Reg. No./Substance:
0/Acetates; 0/Butyrates; 0/Fatty Acids, Volatile; 0/Propionates; 0/Protease Inhibitors; 0/Tissue Inhibitor of Metalloproteinase-1; 127497-59-0/Tissue Inhibitor of Metalloproteinase-2; EC 3.4.21.73/Urokinase-Type Plasminogen Activator; EC 3.4.24.-/Metalloendopeptidases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inwardly rectifying K+ channels in dispersed bovine parathyroid cells.
Next Document:  Overexpression of hepatic pancreatic polypeptide receptors in chronic pancreatitis.